Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ocado Group sees profits surge after strong first half

(Sharecast News) - Ocado Group has said its full-year outlook remains on track after swinging to a big profit in the first half, in which both the tech and logistics divisions delivered double-digit top-line increases.

The company, which offers grocery fulfilment tech as well as owning a 50% share in Ocado Retail with M&S, said that current exclusivity terms with customers are expected to "roll off" in multiple markets towards the end of the year, as it guided to a slight softening of revenue growth over the second half.

"Many of these markets have developed substantially in recent years and the online channel is fully established as the major growth driver in grocery globally. This is an exciting moment to bring the proven, enhanced and even more flexible Ocado offering back to these markets," said chief executive Tim Steiner.

Revenues in the six months to 1 June were up 13.2% at £674.0m, with Technology Solutions revenues up 14.9% and Ocado Logistics revenues up 12.1%.

Adjusted EBITDA surged to £91.8m from £52.0m the year before, while the company booked a statutory profit of £611.8m, compared with a loss of £153.3m previously, with Ocado Retail now reported as an "associated undertaking" following its deconsolidation in April, which resulted in a valuation gain of £782.6m.

Technology Solutions more than doubled operating profits to £72.8m from £34.8m, as adjusted EBITDA margins surged to 26.3% from 14.4%. Meanwhile, Ocado Logistics adjusted EBITDA rose to £19.0m from £17.2m.

For the full year, the company is targeting 10% revenue growth within the tech arm and a high mid-single digit percentage increase within logistics.

Ocado reported an underlying cash outflow of £108m by the end of the year, an improvement from the £201m outflow recorded the year before, with the group stating that its "core priority" was to turn cash flow positive next financial year as it works to improve operating costs, cost profile and capital efficiency.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.